The APx-PACE database tracks the FDA's use of patient experience data in decisions on drugs and biologics approved since 2018. Updated monthly, it provides clients with actionable insights to stay ahead in patient-focused drug development. The database offers:

• Examples of patient experience data submitted to the FDA.

• Insights into how the FDA uses these data in decisions.

• Trends in benefit-risk assessments and patient-centered outcome measures.

We leverage APx-PACE to:

• Provide educational examples of successful patient experience data submissions.

• Advise on data collection and integration into drug development strategies.

Contact us to learn more.